Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
938,623
-
Shares change
-
-24,723
-
Total reported value, excl. options
-
$1,126,777
-
Value change
-
-$44,391
-
Number of buys
-
3
-
Number of sells
-
4
-
Price
-
$1.20
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q2 2023
As of 30 Jun 2023 NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 938,623 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Mayo Clinic, GEODE CAPITAL MANAGEMENT, LLC, SG Americas Securities, LLC, MAI Capital Management, STATE STREET CORP, NORTHERN TRUST CORP, Princeton Global Asset Management LLC, Tower Research Capital LLC (TRC), and Nemes Rush Group LLC.
This table shows 15 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.